Acebutolol Price Trend and Forecast 2026-2027

Acebutolol prices in Germany, the highest-cost reporting region, rose 6.1% in H1 2026, climbing from USD 40.9/KG in Q1 to USD 43.4/KG by Q2 as firmer cardioselective beta-blocker synthesis intermediate costs and recovering antihypertensive and cardiac arrhythmia formulation procurement reversed the brief Q4 2025 market correction. Globally, the average rose from USD 28.85/KG in Q1 to USD 30.58/KG in Q2, a 6.0% gain. For H2 2026, a global average of USD 30.80-34.20/KG is expected, with continued firming on Middle East supply disruptions and growing antihypertensive and cardiac arrhythmia treatment sector demand globally.

Acebutolol is a cardioselective beta-1 adrenergic receptor antagonist with partial intrinsic sympathomimetic activity and membrane-stabilising properties, produced by multi-step chemical synthesis from 4-amino-3-acetoxybutyrophenone or 4-hydroxy acetophenone precursors through acylation, nucleophilic substitution with epichlorohydrin, and aminolysis with isopropylamine to yield the N-[3-(acetylamino)-4-(2-hydroxy-3-isopropylaminopropoxy)phenyl]butanamide hydrochloride active pharmaceutical ingredient. Its cardioselectivity, concentrating beta-1 blockade at cardiac tissue over bronchial beta-2 receptors, provides blood pressure and heart rate control with a reduced bronchoconstriction risk compared to non-selective beta-blockers. The intrinsic sympathomimetic activity produces partial agonism at adrenoceptors, resulting in less resting bradycardia and reduced adverse effects on serum lipid profiles versus other beta-blockers, making it preferred in patients where these properties matter clinically. The largest pull comes from hypertension management, where acebutolol is prescribed as monotherapy or in combination with other antihypertensive agents across adult hypertensive populations. Cardiac arrhythmia management including premature ventricular contractions, supraventricular tachyarrhythmias, and ventricular arrhythmia suppression add significant demand. Angina pectoris treatment adds further consistent demand. Synthesis intermediate costs, antihypertensive prescription volumes, and regional API capacity all feed into the price.

Acebutolol Price Forecast for 2026

The balance of supply and demand for acebutolol through H2 2026 leans moderately firm. Beta-blocker synthesis intermediate costs firmed from Middle East chemical supply disruptions. Antihypertensive prescribing volumes, cardiac arrhythmia management, and growing cardiovascular treatment access are expanding with ageing demographics and hypertension awareness globally.

The main upside risk is synthesis intermediate cost increases alongside accelerating antihypertensive and cardiac arrhythmia treatment access programme procurement. The main downside risk is continued Chinese and Indian API surplus maintaining competitive price pressure below forecast.

For the Quarter Ending June 2026

Acebutolol Prices Q2 2026:

• United States: USD 35.3/KG
• China: USD 24.6/KG
• Germany: USD 43.4/KG
• India: USD 33.5/KG

Acebutolol Prices in the United States

US Acebutolol prices averaged USD 35.3/KG in Q2 2026, up 6.0% from USD 33.3/KG in Q1 2026. Firmer synthesis intermediate costs and recovering antihypertensive and cardiac arrhythmia procurement drove consistent buying through the quarter.

Why did the price of Acebutolol change in Q2 2026 in the United States?

Firmer beta-blocker synthesis intermediate costs raised the API production floor. Hypertension management, ventricular arrhythmia suppression, and angina pectoris formulation procurement lifted buying. Supraventricular tachyarrhythmia treatment demand provided additional support near USD 35.3/KG.

Acebutolol Prices in China

Chinese Acebutolol prices averaged USD 24.6/KG in Q2 2026, up 6.0% from USD 23.2/KG in Q1 2026, the lowest among the tracked markets. Spring antihypertensive and cardiac export and domestic procurement lifted buying. Firmer domestic synthesis costs raised the floor despite domestic API capacity.

Why did the price of Acebutolol change in Q2 2026 in China?

Spring antihypertensive and cardiac arrhythmia export and domestic procurement lifted buying. Firmer domestic beta-blocker synthesis intermediate costs raised the production floor. Domestic API capacity kept China the most affordable source.

Acebutolol Prices in Germany

German Acebutolol prices averaged USD 43.4/KG in Q2 2026, up 6.1% from USD 40.9/KG in Q1 2026, the highest among the tracked markets. Higher synthesis intermediate and energy costs elevated European API production economics. Consistent antihypertensive, cardiac arrhythmia, and angina demand maintained steady buying.

Why did the price of Acebutolol change in Q2 2026 in Germany?

Higher beta-blocker synthesis intermediate and energy costs elevated European API production economics. Middle East supply disruptions added cost premiums to synthesis substrate chains. Consistent hypertension, arrhythmia, and angina formulation procurement maintained buying near USD 43.4/KG.

Acebutolol Prices in India

Indian Acebutolol prices averaged USD 33.5/KG in Q2 2026, up 6.0% from USD 31.6/KG in Q1 2026. Growing antihypertensive and cardiac export and domestic demand supported buying. Firmer synthesis import costs raised the production floor.

Why did the price of Acebutolol change in Q2 2026 in India?

Growing antihypertensive and cardiac arrhythmia export and domestic procurement lifted buying. Firmer beta-blocker synthesis import costs raised the production floor. Angina pectoris and arrhythmia export demand provided additional buying support near USD 33.5/KG.

For the Quarter Ending March 2026

Acebutolol Prices Q1 2026:

• United States: USD 33.3/KG
• China: USD 23.2/KG
• Germany: USD 40.9/KG
• India: USD 31.6/KG

Acebutolol Prices in the United States

US Acebutolol prices averaged USD 33.3/KG in Q1 2026, recovering about 2.1% from Q4 2025. Recovering antihypertensive and cardiac demand and firming synthesis costs held the market near USD 33.3/KG.

Why did the price of Acebutolol change in Q1 2026 in the United States?

Recovering antihypertensive and cardiac arrhythmia procurement maintained buying. Firming synthesis intermediate costs raised the production floor. The market recovered to USD 33.3/KG from the Q4 2025 correction.

Acebutolol Prices in China

Chinese prices averaged USD 23.2/KG in Q1 2026, recovering about 2.2% from Q4 2025. Post-Lunar New Year antihypertensive restocking and firming synthesis costs held the market near USD 23.2/KG.

Why did the price of Acebutolol change in Q1 2026 in China?

Post-Lunar New Year antihypertensive and cardiac export restocking lifted buying. Firming domestic synthesis costs raised the floor. The market recovered to USD 23.2/KG from the Q4 2025 correction.

Acebutolol Prices in Germany

German prices averaged USD 40.9/KG in Q1 2026, recovering about 2.0% from Q4 2025. Recovering antihypertensive and cardiac demand and firming synthesis and energy costs held the market near USD 40.9/KG.

Why did the price of Acebutolol change in Q1 2026 in Germany?

Recovering antihypertensive and cardiac arrhythmia procurement maintained buying. Firming synthesis intermediate and energy costs held the production floor. The market recovered to USD 40.9/KG from the Q4 2025 correction.

Acebutolol Prices in India

Indian prices averaged USD 31.6/KG in Q1 2026, recovering about 1.9% from Q4 2025. Growing antihypertensive and cardiac export and domestic demand and firming import costs held the market near USD 31.6/KG.

Why did the price of Acebutolol change in Q1 2026 in India?

Growing antihypertensive and cardiac arrhythmia export and domestic procurement maintained buying. Firming synthesis import costs raised the floor. The market recovered to USD 31.6/KG from the Q4 2025 correction.

Quarterly Acebutolol Price Trends

Global Acebutolol prices rose in Q3 2025 on the antihypertensive season, dipped in Q4 2025 on synthesis cost moderation, then recovered through Q1 and Q2 2026. The average rose from USD 28.0/KG in Q2 2025 to USD 28.56/KG in Q3, eased to USD 28.28/KG in Q4, then firmed to USD 28.85/KG in Q1 2026 and USD 30.58/KG in Q2 2026, a net gain of about 9.2% over the window. Beta-blocker synthesis intermediate cost cycles and antihypertensive and cardiac procurement drove the overall pattern.

What was Acebutolol Price in 2025?

Acebutolol prices firmed modestly through 2025 on consistent antihypertensive and cardiac management demand. The global average opened near USD 27.8/KG in Q1 2025 and closed at USD 28.28/KG in Q4, a full-year gain of about 1.7%. Synthesis intermediate cost dynamics and antihypertensive and cardiac procurement drove the quarterly pattern throughout the year.

Acebutolol Prices in the United States in 2025

US prices firmed from about USD 32.2/KG in Q1 2025 to USD 32.6/KG by Q4, a gain of 1.2%. Consistent antihypertensive, arrhythmia, and angina management demand maintained the modest upward trend.

Acebutolol Prices in China in 2025

Chinese prices firmed from roughly USD 22.4/KG in Q1 2025 to USD 22.7/KG by Q4, a gain of 1.3%. Growing antihypertensive export and domestic demand drove modest firming through the year.

Acebutolol Prices in Germany in 2025

German prices firmed from about USD 39.6/KG in Q1 2025 to USD 40.1/KG by Q4, a gain of 1.3%. Consistent antihypertensive, arrhythmia, and cardiac demand and firm synthesis costs supported.

Acebutolol Prices in India in 2025

Indian prices firmed from roughly USD 30.6/KG in Q1 2025 to USD 31.0/KG by Q4, a gain of 1.3%. Growing antihypertensive and cardiac export and domestic demand drove modest firming through the year.

How We Can Help

Expert Market Research: Your Source for Real-Time Acebutolol Price Intelligence

Expert Market Research tracks Acebutolol prices continuously across every major producing and consuming region. The team traces causation through beta-blocker synthesis intermediate economics, antihypertensive and cardiac arrhythmia prescription cycles, and regional API production capacity. Contact Expert Market Research today for Acebutolol pricing data, bespoke market analysis, and strategic procurement advisory.